`
`
`
` RESEARCH
`
`
`
`
` APPLICATION NUMBER:
`
`
`208276Orig1s000
`
`
` OFFICER/EMPLOYEE LIST
`
`
`
`
`
`
`
`
`
`MEMORANDUM
`
`DEPARTMENT OF HEALTH AND HUMAN SERVICES
`PUBLIC HEALTH SERVICE
`FOOD AND DRUG ADMINISTRATION
`CENTER FOR DRUG EVALUATION AND RESEARCH
`
`DATE:
`
`March 25, 2019
`
`TO:
`
`Administrative file for NDA 208276
`
`FROM:
`
`WAYNE AMCHIN, Regulatory Health Project Manager
`Division of CARDIOVASCULAR AND RENAL PRODUCTS, Office of DRUG
`
`EVALUATION I
`
`SUBJECT: Officer/Employee List for NDA 208276
`
`
`APPLICATION/DRUG:
`
`NDA 208276 REMODULIN (TREPROSTINIL) INJECTION
`
`
`The following officers or employees of FDA participated in the decision to approve this
`application and consented to be identified on this list:
`
`Adams, Grafton
`Amchin, Wayne
`Fromm, Edward
`Garnett, Christine
`Gordon, Maryann
`Hariharan, Sudharshan
`Lyons, Darrell
`Metcalfe, John
`Monteleone, Michael
`Sahin, Leyla
`Stockbridge, Norman
`Tesfamariam, Belay
`Wilson, Wendy
`
`Reference ID: 4409052
`
`(
`
`
`
`